Safety Rates Drug Report: RITUXIMAB Ischaemic cardiomyopathy adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: RITUXIMAB Injury: Ischaemic cardiomyopathy Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 1 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
96244428	RITUXIMAB	Ischaemic cardiomyopathy	TEVA	73.39 YR	M	98 KG	20160720	US

|< 1/2 << Previous Page Page 1

Total Records: 1 Number of Pages: 1

Execution Time: 0.21414303779602 seconds (ucode:5141653). Developed by: James D. Barger